Ranbaxy CEO to demit office by October end

As per reports, Mr Arun Sawhney, CEO and managing director of Ranbaxy which is now a part of Sun Pharma, will retire on October 31, 2015


Image courtesy: Sahara Samay

Mr Arun Sawhney has held the top position at the Ranbaxy for last seven years. During his tenure, the company went through a lot of tribulations ranging from tough regulatory actions mostly in the US to the acquisitions by other pharma companies.

Mr Sawhney who has turned 60, joined Ranbaxy in 2008. It was the same time when the Japanese major Daiichi-Sankyo had acquired the firm. He had then taken over as the head of the API (active pharmaceutical ingredient) business and global manufacturing and supply chain. He is credited with managing the Ranbaxy through its deepest crisis like a fine of $500 million. He is also known for his management skills that include the successes such as approval of blockbuster opportunities like Lipitor generic in the US.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email